Clinical Trials Directory

Trials / Completed

CompletedNCT04696757

Non-OpeRative MANagement of Rectal Cancer Patients

Non-OpeRative MANagement of Rectal Cancer Patients Who Had Clinical Complete Response After Pre-operative Chemo-raDiotherapY

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
18 (actual)
Sponsor
Kangbuk Samsung Hospital · Academic / Other
Sex
All
Age
20 Years – 100 Years
Healthy volunteers
Not accepted

Summary

This study is a single-center, open, prospective, single-treatment trial (pilot study). This study aims to analyze the treatment results after receiving capecitabine adjuvant chemotherapy for 4 months after non-surgical treatment in patients who had completed and could have clinical complete remission with capecitabine preoperative chemoradiotherapy with capecitabine for mid-to-lower rectal cancer and to investigate the feasibility of non-surgical treatment.

Detailed description

Indication: 1. mid-to-lower rectal cancer was diagnosed histologically as adenocarcinoma in preoperative examination, 2. the tumor was located at the lower boundary of the tumor spans the anorectal junction, and the clinical stage is stage 2 or 3, and 3. clinical complete remission was confirmed after the treatment response evaluation at 8 weeks after completion of preoperative chemoradiotherapy according to MR/SFS and biopsy. Aim: 1. to analyze the treatment results after receiving capecitabine adjuvant chemotherapy for 4 months after non-surgical treatment in patients who had completed and could have clinical complete remission with capecitabine preoperative chemoradiotherapy with capecitabine for mid-to-lower rectal cancer 2. to investigate the feasibility of non-surgical treatment.

Conditions

Interventions

TypeNameDescription
DRUGCapecitabineCapecitabine without surgery

Timeline

Start date
2018-02-01
Primary completion
2024-12-31
Completion
2024-12-31
First posted
2021-01-06
Last updated
2025-02-12

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT04696757. Inclusion in this directory is not an endorsement.